NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
9.99
-0.10 (-0.99%)
Apr 25, 2025, 11:43 AM EDT - Market open
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees
2,200
Change (1Y)
100
Growth (1Y)
4.76%
Revenue / Employee
$300,257
Profits / Employee
-$35,785
Market Cap
1.29B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
NEO News
- 3 days ago - NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting - Business Wire
- 17 days ago - NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025 - Business Wire
- 18 days ago - NeoGenomics Completes Acquisition of Pathline - Business Wire
- 24 days ago - Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics - Business Wire
- 6 weeks ago - NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline - Business Wire
- 2 months ago - NeoGenomics: Decent Fundamentals, But Still Overvalued - Seeking Alpha
- 2 months ago - NeoGenomics to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - NeoGenomics, Inc (NEO) Q4 2024 Earnings Call Transcript - Seeking Alpha